References

Camps T, Amat M, Manteca X. A Review of medical conditions and behavioral problems in dogs and cats. Animals. 2019; 9:(12) https://doi.org/10.3390/ani9121133

DePorter T, Landsberg GM, Horwitz D. Tools of the trade: Psychopharmacology and Nutrition. In: Rodan I, Heath S (eds). : Elsevier; 2016

Korpivaara M, Huhtinen M, Aspegrén J, Overall K. Dexmedetomidine oromucosal gel reduces fear and anxiety in dogs during veterinary visits: A randomised, double-blind, placebo-controlled clinical pilot study. Vet Rec. 2021; 189:(12) https://doi.org/10.1002/vetr.832

Mills DS, Demontigny-Bédard I, Gruen M Pain and problem behavior in cats and dogs. Animals. 2020; 10:(2) https://doi.org/10.3390/ani10020318

Overall K. Manual of Clinical Behavioural Medicine for Dogs and Cats.: Elsevier; 2013

Plumb DC. Plumb's Veterinary Drug Handbook, 9th edition. : Wiley; 2018

Preskorn SH. Prediction of individual response to antidepressants and antipsychotics: an integrated concept. Dialogues Clin Neurosci. 2014; 16:(4)545-554 https://doi.org/10.31887/DCNS.2014.16.4/spreskorn

Riemer S, Heritier C, Windschnurer I, Pratsch L, Arhant C, Affenzeller N. A Review on Mitigating Fear and Aggression in Dogs and Cats in a Veterinary Setting. Animals. 2021; 11:(1) https://doi.org/10.3390/ani11010158

Sinn L. Advances in Behavioral Psychopharmacology. Vet Clin Small Anim. 2018; 48:457-471 https://doi.org/10.1016/j.cvsm.2017.12.011

van Haaften KA, Grigg EK, Kolus C, Hart L, Kogan LR. A survey of dog owners' perceptions on the use of psychoactive medications and alternatives for the treatment of canine behavior problems. Journal of Veterinary Behavior. 2020; 35:27-33 https://doi.org/10.1016/j.jveb.2019.10.002

Veterinary Medicines Directorate (VMD) 2021 Guidance. The Cascade: prescribing unauthorised medicines. 2021. https://writing.wisc.edu/handbook/documentation/doccse/nameyear/ (accessed 10 June 2021)

Warnes CE. Using psychopharmacology in the treatment of problem behaviours in dogs and cats. Companion Animal. 2021; 26:(9)1-10 https://doi.org/10.12968/coan.2021.0032

The use of behaviourally-active medication in companion animals part 1

02 April 2022
15 mins read
Volume 13 · Issue 3

Abstract

Behaviour cases are common in general practice and veterinary nurses can play a vital role in their identification and management. Full behavioural assessment and implementation of a behaviour modification protocol remains essential, but increasingly animals may also be prescribed psychoactive medications. This three-part article aims to give veterinary nurses a comprehensive introduction to the principles of using behaviourally-active medication in companion animals. Part 1 contains an overview of the main types of behaviourally active drugs available for treating dogs and cats in the UK, and the different types of behavioural problems that they can potentially help. This will be followed in Part 2 by a more detailed look at the decision-making process for using short-acting behaviourally-active medications, supported by case examples. Part 3 will outline ways in which veterinary nurses can contribute to improving the behavioural welfare of their patients generally, including through identifying and supporting those animals that will benefit from behaviourally active medication.

The use of drugs to influence behaviour, including altering mood and emotional responses, is known as psychopharmacology. In veterinary medicine, behaviourally-active medication is most commonly used in dogs, and to a lesser extent in cats. Behaviourally-active drugs will generally either have a calming effect, for example through reducing anxiety and/or causing mild sedation, or they can have a longer-term effect on reducing negative emotional responses, such as anxiety, fearfulness or frustration, which can reduce stress and improve wellbeing generally.

Behaviourally-active drugs can improve welfare in animals in both the short and longer term, and can also play an important role in the successful treatment of some problem behaviours. Used judiciously, their calming effects can make fearful animals easier, and safer, to handle in the veterinary surgery as well as in other environments, and they can also reduce the risk of animals becoming even more fearful in these environments in future.

Although the Veterinary Surgeons Act 1966 legally prevents veterinary nurses from prescribing medication, in the course of their work, they are very likely to encounter animals that would benefit from behaviourally-active medication either to facilitate handling in the veterinary surgery or to address problem behaviours or situations that are detrimental to an animal's welfare in other contexts. Therefore, veterinary nurses in general practice should ideally have an understanding of psychopharmacology, including an awareness of what drugs are available and how they work. They may also be asked about behavioural medication by owners, for example to help dogs fearful of noises in the run-up to the firework period. Owners of animals already on behaviourally active medication may also seek help and support from veterinary nurses, for example if they have concerns about potential side effects or lack of any obvious behavioural improvement.

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.